Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Tax Exempt)
- SAM.gov registration date
- Physical address
- 11011 Via Frontera, San Diego, CA 92127, USA
- Website
- absinstitute.org
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Scripps Research Institute | R56AI203658 | $432,833 | |
| Scripps Research Institute | R01AI181784 | $476,877 | |
| Scripps Research Institute | R01AI181784 | $462,571 | |
| Scripps Research Institute | R01AI181784 | $48,724 | |
| Scripps Research Institute | R01AI181784 | $428,153 |
Similar vendors
About the company
Applied Biomedical Science Institute, a San Diego-based nonprofit research organization, conducts National Institutes of Health-funded biomedical research as a prime grant recipient, with a focus on immunology and infectious-disease therapeutics centered on novel antibody and peptide structures derived from cattle immune systems.
The Institute's federal footprint is concentrated in health research grants from the Department of Health and Human Services. Nine awards across the vendor portfolio (78% prime recipient, 22% sub-recipient) total $27.5 million obligated across all sources. The National Institute of Allergy and Infectious Diseases (NIAID) accounts for seven awards. Recent prime grants include a $976,318 Project Grant awarded April 6, 2026 (CFDA 93.855, Allergy and Infectious Diseases Research), with completion targeted for March 31, 2031, focused on elucidating molecular mechanisms of ultralong complementarity-determining region H3 (CDR H3) antibodies produced by cattle—specifically understanding the atypical V(D)J recombination events and adenine-rich insertional sequences that generate these structures. The Institute also holds a June 9, 2023 NIAID Project Grant (completion May 31, 2028) for developing broadly neutralizing SARS-CoV-2 peptidic knobs derived from cow antibodies, using X-ray crystallography, electron microscopy, and nuclear magnetic resonance spectroscopy to characterize knob structures and antigen-binding mechanisms. The Institute's technical capability bridges structural biology with therapeutic peptide design, targeting vaccine development and therapeutic antibody applications against coronavirus and HIV-1. As a subrecipient, the Institute performs work under the Scripps Research Institute on HIV-1 broadly neutralizing antibody elicitation (sub-award dated December 1, 2023). Award activity is episodic—one grant in 2017, 2019, and 2020, then two in 2023 and two in 2026—with only one award facing recompete inside the next twenty-four months.
Quick answers
Is Applied Biomedical Science Institute registered in SAM.gov?
Yes. Applied Biomedical Science Institute's SAM.gov registration is active through January 30, 2027.
What is Applied Biomedical Science Institute's CAGE code?
Applied Biomedical Science Institute's CAGE code is 85ZM0, and its Unique Entity ID (UEI) is K6YFV76PCGB7.
What is Applied Biomedical Science Institute's most recent federal award?
Applied Biomedical Science Institute's most recent federal grant award is Unique antibody structural variegation mechanisms (R01AI189981), from National Institute of Allergy and Infectious Diseases (NIH), on April 6, 2026.
On GovTribe
See Applied Biomedical Science Institute's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors